Optimising Medication Management and Use of Antithrombotic Agents
A special issue of Pharmacy (ISSN 2226-4787). This special issue belongs to the section "Pharmacy Practice and Practice-Based Research".
Deadline for manuscript submissions: closed (1 January 2024) | Viewed by 1808
Special Issue Editor
Interests: optimising outcomes of antithrombotic agents; stroke prevention in atrial fibrillation; quality use of medicines; medication-related services along the continuum of care
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The suboptimal use of antithrombotic agents, including under-prescribing where antithrombotic therapy is clinically indicated, remains a major cause of medication-related harm, hospital admissions and mortality. Contemporary guidelines have highlighted the importance of an integrated, multidisciplinary and patient-centered approach to optimise patient outcomes across a range of disease states where antithrombotic agents are indicated. Pharmacists play a number of vital roles within these multidisciplinary teams, from promoting evidence-informed prescribing (and deprescribing where warranted) and facilitating patient monitoring and medication management review to providing adherence support and educating patients to allow active engagement in shared decision-making and self-management. In the past three years, the COVID-19 pandemic has created enormous challenges in healthcare worldwide, but these challenges have created new opportunities for pharmacists to contribute to medication management in innovative ways and across a variety of settings. I look forward to receiving your submissions describing how pharmacists can contribute to optimising medication management in the use of antithrombotic agents in this evolving world of healthcare.
I therefore invite you to submit original research articles, reviews or case reports for this Special Issue on optimising medication management in the use of antithrombotic agents.
Dr. Leanne Chalmers
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antithrombotic agents
- pharmacist
- evidence-informed practice
- medication management
- patient education
- quality improvement
